Trial intelligence / Profile preview

Topical Hemp-based Extract for Skin Rejuvenation

NCT05734703Phase 1Unknown

Sponsor
Medical Life Care Planners
Start
Mar 2023
Primary completion
Jun 2023
Countries
1
01

Overview

Phase 1, open-label, single-arm trial in Skin aging, sponsored by Medical Life Care Planners. Primary endpoints: Dermal-epidermal junction flattening at 90 days, Elastic fiber attenuation at 90 days and 1 more. Status: unknown.

02

Conditions

Skin aging

Beyond the preview

Go deeper on NCT05734703.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05734703.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call